BCO Pharma is a late development stage healthcare company that develops products for the unique needs of pediatric or other vulnerable patient populations. The company's lead product is a unique pediatric formulation of an inotrope that is used to treat hypotension in critically ill babies and children. The phase III trial supporting the product is now finished and an application for a marketing authorization in the EU will be submitted in August of 2022.
| Website | http://www.bcopharma.com |
| Revenue | $1 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2009 |
| Address | Bank House, Cork, Munster, IE |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Other Healthcare Technology Systems, Manufacturing, Drug Discovery |
| Keywords | Pharmaceutical Development, Biopharmaceutical Research, Drug Delivery Systems, Innovative Pharmaceuticals, Child Health Products, New Drug Applications, Healthcare Solutions, Life Saving Medicines, Pediatric Cardiology, Neonatal Care |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Gilead Sciences +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular BCO Pharma employee's phone or email?
BCO Pharma Questions
The BCO Pharma annual revenue was $1 million in 2026.
Seamus O'Loan is the CEO of BCO Pharma.
1 people are employed at BCO Pharma.
BCO Pharma is based in Cork, Munster.
The NAICS codes for BCO Pharma are [325, 32541, 32, 3254].
The SIC codes for BCO Pharma are [28, 283].
Top BCO Pharma Employees
-
Seamus O'Loan
Chief Executive Officer at BCO Pharma
Tiburon, CA, US25
Related Companies
